FDA has granted approval to the Abbreviated New Drug Application (ANDA) filed by Taro Pharmaceutical Industries Ltd. for Lamotrigine Tablets. The product is used in the treatment of seizures and the tentative FDA approval means that the tablets meet the substantive requirements for approval, but can be marketed only after the final approval has been granted.